Searched for
DRUG LICENSING AGREEMENTS
Google poised to lose two more senior AI staffers to AnthropicTheir moves rattled investors and cast new doubt on Google’s ability to compete in the fierce race to build better models.Shares of Alphabe...- Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supplyUzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...
- Taliban inks maiden defence pact with Russia as Kabul seeks muscleThe pact was signed following a meeting between Taliban defence minister Mawlawi Mohammad Yaqoob and Sergei Shoigu, secretary of Russia's S...
- AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...
- Profit on paper, loss in reality: How a routine accounting tool is used to deceive and take investors for a rideAmortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...
- Ohio surgeon faces serious charges after using ex-wife’s identity to obtain abortion pills for pregnant girlfriend, pleads no contestA former Toledo surgeon, Hassan-James Abbas, faces up to five years in prison after pleading no contest to charges including unlawful distr...
- US raises concerns at India’s duties on IP-intensive goods, source code, AI working paperThe US has voiced concerns over India's high customs duties on IP-intensive products and its proposed mandatory blanket license for AI deve...
- Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipelineGilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...
- Mankind Pharma in licensing pact with Takeda to market acidity drug Vonoprazan in IndiaMankind Pharma partners with Takeda to introduce Vonoprazan for GERD, oesophagitis, ulcers, and Helicobacter pylori in India. EVP Ramesh st...
- Zydus, Lupin enter licensing pact to market drug to treat liver diseaseZydus launched the drug under the brand names Lipaglyn and Bilypsa and will continue to market them. Lupin will pay Zydus upfront licensing...
- US nod in Hand, Pfizer is looking for partners to make Covid drug in IndiaThe company has begun investing $1 billion, at risk, in the manufacture of its potential Covid-19 oral antiviral drug with the goal of maki...
- Pfizer to allow generic versions of its COVID-19 pill in 95 countriesThe voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified ...
- MSD enters pact with UN-backed MPP to license COVID drug molnupiravir in 105 countries including IndiaUnder the terms of the agreement, MPP will be permitted to further license non-exclusive sub-licences to manufacturers and diversify the ma...
- MSD in talks with Medicines Patent Pool for additional licenses for molnupiravirMSD entered into a voluntary licensing agreement with five Indian drug makers including Sun Pharma, Cipla, Dr. Reddy’s, Emcure and Hetero f...
- These are the companies manufacturing COVID-19 drug Remdesivir in India
- Gilead sign licensing deal for Remdesivir with three Indian companiesET had reported on May 5 that Gilead Sciences was in talks with several Indian companies including Jubilant Life Sciences for a licensing d...
- Gilead's hepatitis C drug licensing to benefit more patients: SitharamanA delegation of Gilead Sciences Inc yesterday met Commerce and Industry Minister Nirmala Sitharaman and informed about the signing of non-e...
- Glenmark inks licence, supply pact with TaroGlenmark Pharmaceuticals on Thursday said it has signed a licence and supply agreement with Israeli firm Taro Pharmaceuticals to sell a bra...
- Elder Pharma, Israel co enter in-licensing dealMumbai-based Elder Pharmaceuticals has signed an exclusive in-licensing agreement with Israeli biotech company Enzymotec for the marketing ...
- JB Chem ties up with US co for anti-HIV drugJB Chemicals & Pharmaceuticals Ltd on Friday said it has signed a non-exclusive license agreement with US-based Gilead Sciences Inc to manu...
Load More
